Nirvana Life Sciences Inc. Announces the Appointment of Sheldon Inwentash to the Board of Directors Psychedelics Investing
Awakn Life Sciences Signs Its Third Licensing Partnership Agreement in North America, and First in New York Company News
Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day Psychedelics Investing
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights Psychedelics Investing
COMPASS Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine Psychedelics Investing
Silo Wellness Breaking News: Jackson County Oregon's Proposed TPM Restrictions Put Rural Psilocybin Retreat Therapy Centers at Risk Psychedelics Investing
Silo Wellness to Testify on Oregon Psilocybin Therapy Land Use Restrictions at Jackson County Planning Commission's Thursday Hearing; Other Corporate Updates Psychedelics Investing
